@PatentBuddy

Overlapping Ranges in Claims and Prior Art Result in Invalidation of Patent on Transdermal Patch for Parkinson’s Disease | Patently-O

Intellectual property law

Patently-O
Overlapping Ranges in Claims and Prior Art Result in Invalidation of Patent on Transdermal Patch for Parkinson's Disease
By Chris Holman
UCB, Inc. v. Actavis Lab'ys UT, Inc., 2023 WL 2904757, - 4th - (Fed.Cir.Apr. 12, 2023)
Rotigotine is a drug used to treat Parkinson's disease.People with Parkinson's disease experience significant gastrointestinal dysfunction, such as difficulty swallowing, which can frustrate the oral administration of drugs.
[
customize summary
]
[
]
[ post ]